Anti-Aβ mAbs cause ARIAs, which result in edema (ARIA-E) and hemorrhage (ARIA-H) that affect 20–40% of patients, with a higher risk observed in APOE4 carriers [17]. This evidence concerns the gene APOE and hemorrhage.